To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
Clinical trial NCT05106023 · UNKNOWN
Trial details
- NCT number
- NCT05106023
- Sponsor
- Yong Chen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2023-09-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.